2018 premiums in the federally-facilitated health insurance exchanges were an average 50% higher in areas with only one insurer and 21% higher in areas with only two insurers, according to a study reported today in Health Affairs. The study explores three potential theories about why exchange premiums are higher in some areas than in others (enrollee health, provider market power, and insurer market power), and concludes that “insurer monopoly is the most important predictor of premium levels and growth rates.” More than four in 10 rating areas in the 2018 exchanges had monopolist insurers and 22% of plan enrollees had only one insurance option during the last open enrollment period, the study found. “This study debunks any notion that higher health insurance premiums are easily attributable to provider concentration,” said AHA General Counsel Melinda Hatton.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services is launching a new initiative for state Medicaid programs to purchase prescription drugs at prices aligned…
Headline
The White House announced today that it reached agreements with Eli Lilly and Novo Nordisk to align their drug prices with the lowest paid by other developed…
Headline
The AHA collaborated with LCMC Health in New Orleans to spotlight innovative efforts that extend care beyond hospital walls. LCMC Health supports families…
Headline
Cigna’s Evernorth division Oct. 27 announced a new, rebate-free pharmacy benefit model, beginning in 2027, that would reduce monthly prescription drug costs by…
Headline
The median net launch price for 154 new drugs increased 51% between 2022 and 2024, after accounting for inflation and discounts, according to a report released…
Headline
A report by the Department of Health and Human Services Office of the Inspector General found that many Medicare Advantage and Medicaid managed care plans…